TransMedics Group (NasdaqGM:TMDX) Q3 2025 Earnings Call October 29, 2025 04:30 PM ET Speaker4Good afternoon and welcome to the TransMedics Group Inc. third quarter 2025 earnings conference call. At this time, all participants are in the listen-only mode. We will be facilitating a question-and-answer session towards the end of today's call. As a reminder, this call is being recorded for replay purposes. If you require operator assistance, please press star and then zero. I would now like to turn the call ove ...

GE HealthCare Technologies (NasdaqGS:GEHC) Q3 2025 Earnings Call October 29, 2025 08:30 AM ET Company ParticipantsVijay Kumar - Senior Managing Director, Equity ResearchJoanne Wuensch - Managing DirectorCarolynne Borders - Chief Investor Relations OfficerJay Saccaro - VP and CFOPeter Arduini - President and CEODavid Roman - Managing DirectorTravis Steed - Managing Director, Equity Research, Medical TechnologyAnthony Petrone - Managing Director Equity ResearchPatrick Wood - Managing DirectorConference Call P ...

GE HealthCare Technologies (NasdaqGS:GEHC) Q3 2025 Earnings Call October 29, 2025 08:30 AM ET Company ParticipantsVijay Kumar - Senior Managing Director, Equity ResearchJoanne Wuensch - Managing DirectorCarolynne Borders - Chief Investor Relations OfficerJay Saccaro - VP and CFOPeter Arduini - President and CEODavid Roman - Managing DirectorTravis Steed - Managing Director, Equity Research, Medical TechnologyAnthony Petrone - Managing Director Equity ResearchPatrick Wood - Managing DirectorConference Call P ...

Study to evaluate potential to reduce cardiac MRI demand and expand access to advanced heart diagnostics across care settingsToronto, Ontario – TheNewswire - October 29, 2025 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) today announced it has entered into a collaboration with Providence Health Care Ventures (“PHC Ventures”) to validate the Company’s VMS+™ platform at St. Paul’s Hospital in Vancouver, British Columbia. The collaboration will evaluate how artificial ...

GE HealthCare Technologies' said profit fell in the third quarter, weighed down by the added costs of tariffs. ...

DALLAS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the third quarter ended September 30, 2025 on Tuesday, November 11, 2025 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time that day to discuss th ...

BURLINGTON, Mass. and JERUSALEM, Oct. 28, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will report its third quarter 2025 financial results, as well as operational highlights, before the open of the U.S. financial markets on Tuesday, November 11, 2025. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss th ...

本周上海共发生16起融资，张江有2起，临港有1起。 2. 融资企业动态 1. 一周融资概述 （1）近日，钧合原子与上海交通大学签订先进核能系统联合实验室共建协议； （2）10月24日，戴西软件联合信通院共建国家算力互联网服务平台。 3. 热点行业聚焦 01 融资综述 加冕研究院据张通社Link数据库统计，本周（10.20 – 10.26），上海企业共发生16起融资事件，其中有11起披露了融资金额，合计金额约11.88亿元。本期 与上期（16起）融资事件数相同。 从行政区域分布来看，本周上海共有7区发生融资事件。闵行区融资事件数量最多，有6起，浦东新区以1起之差仅次于闵行区，有5起。松江区发生1起先 进制造领域的大额融资事件，涉及融资金额5亿元。 （1）10月20日，普冉股份投资100万美元设立香港全资子公司； （2）10月23日，果纳半导体收购芯导精密； （3）10月24日，沐曦股份过会。 从融资轮次来看，本周上海融资A轮最多，有5起；其次是天使轮和战略融资，各有3起。本周B轮融资涉及1起5亿元大额融资，战略融资涉及融资金额总 和达3.755亿元。 从行业分布来看，本周上海融资共涉及8个行业，集成电路融资事件 ...

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced, that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the UBS Global Healthcare Conference at 8:00 a.m. ET on Monday, Nov. 10 2025. A ...

公司财务信息发布安排 - 公司将于2025年11月5日美国东部时间上午9点网络直播其2025年第二季度财务业绩和业务亮点电话会议 [1] - 公司将在电话会议当天市场开盘前发布详细财务业绩的新闻稿 [1] - 电话会议由首席执行官Dave Pacitti和高级副总裁兼首席财务官Scott Galovan主持 [1] 投资者沟通渠道 - 可通过电话即时加入会议，需在会议开始前通过链接注册，或拨打1-646-357-8785或1-800-836-8184由接线员接入 [2] - 电话会议及相关演示文稿的同步网络直播可通过公司官网投资者关系部分获取 [3] - 电话会议结束后两小时内可获取回放，回放将保留一周，也可通过拨打1-646-517-4150或1-888-660-6345并输入密码21545收听回放 [3] 公司业务概况 - 公司是一家医疗技术公司，专注于提供临床卓越的医疗设备解决方案，总部位于佐治亚州阿尔法利塔 [4] - 公司致力于解决当今重要的医疗需求，包括为从医院到家的患者提供营养支持，以及减少阿片类药物使用并帮助患者从手术中恢复 [4] - 公司全球范围内开发、制造和销售其知名品牌，在多个产品类别中占据领先的市场地位 [4] 近期公司动态 - 公司宣布收购私有企业Nexus Medical LLC，以加强其在重症监护领域的营养和药物输送业务 [5] - 公司宣布任命Scott Galovan为高级副总裁兼首席财务官，并任命David Pacitti为董事会成员 [6]